- Filed
- Mar 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 3, 2025 | 35.33M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 32.24M sh |
| Capex | FY 2024 · Dec 31, 2023 | $2.05M |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$25.06M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $121.04M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $22.55M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $37.49M |
| Current Assets | FY 2024 · Dec 31, 2023 | $173.79M |
| Total Assets | FY 2024 · Dec 31, 2023 | $202.98M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$1.13 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$1.13 |
| Sga Expense restated | FY 2024 · Dec 31, 2023 | $46.07M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $21.9M |
| Net Income | FY 2024 · Dec 31, 2023 | −$36.4M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$42.76M |
| Gross Profit | FY 2024 · Dec 31, 2023 | $25.32M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $24.91M |
| Revenue | FY 2024 · Dec 31, 2023 | $50.23M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $190.6M |